WELL Health Technologies Past Earnings Performance
Past criteria checks 2/6
WELL Health Technologies has been growing earnings at an average annual rate of 60.5%, while the Healthcare industry saw earnings growing at 16.2% annually. Revenues have been growing at an average rate of 52.4% per year. WELL Health Technologies's return on equity is 10.3%, and it has net margins of 7.7%.
Key information
60.5%
Earnings growth rate
59.4%
EPS growth rate
| Healthcare Industry Growth | -6.7% |
| Revenue growth rate | 52.4% |
| Return on equity | 10.3% |
| Net Margin | 7.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?
Nov 11
Is WELL Health Technologies (TSE:WELL) A Risky Investment?
Sep 09Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher
Jul 05WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price
Jun 11WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem
May 21WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Mar 21Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?
Feb 29The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)
Jan 18WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Oct 30We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt
Jul 17WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Apr 18Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 40%?
Jan 13Should You Think About Buying WELL Health Technologies Corp. (TSE:WELL) Now?
Nov 11Is WELL Health Technologies Corp. (TSE:WELL) Potentially Undervalued?
Aug 09WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 43% Above Its Share Price
May 31Revenue & Expenses Breakdown
How WELL Health Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 958 | 73 | 297 | 0 |
| 30 Jun 24 | 910 | 147 | 291 | 0 |
| 31 Mar 24 | 838 | 30 | 281 | 0 |
| 31 Dec 23 | 776 | 0 | 270 | 0 |
| 30 Sep 23 | 701 | -7 | 255 | 0 |
| 30 Jun 23 | 643 | -4 | 240 | 0 |
| 31 Mar 23 | 612 | -5 | 230 | 0 |
| 31 Dec 22 | 569 | 1 | 215 | 0 |
| 30 Sep 22 | 528 | -29 | 203 | 0 |
| 30 Jun 22 | 482 | -37 | 184 | 0 |
| 31 Mar 22 | 403 | -45 | 150 | 0 |
| 31 Dec 21 | 302 | -44 | 114 | 0 |
| 30 Sep 21 | 204 | -29 | 78 | 0 |
| 30 Jun 21 | 117 | -21 | 48 | 0 |
| 31 Mar 21 | 66 | -9 | 31 | 0 |
| 31 Dec 20 | 50 | -4 | 24 | 0 |
| 30 Sep 20 | 43 | -9 | 20 | 0 |
| 30 Jun 20 | 39 | -10 | 18 | 0 |
| 31 Mar 20 | 36 | -8 | 16 | 0 |
| 31 Dec 19 | 33 | -8 | 14 | 0 |
| 31 Dec 18 | 9 | -2 | 4 | 0 |
| 31 Oct 18 | 6 | -2 | 4 | 0 |
| 31 Jul 18 | 4 | -6 | 3 | 0 |
| 30 Apr 18 | 2 | -6 | 1 | 0 |
| 31 Jan 18 | 0 | -6 | 1 | 0 |
| 31 Oct 17 | 0 | -1 | 1 | 0 |
| 31 Jul 17 | 0 | -1 | 1 | 0 |
| 31 Mar 17 | 0 | 0 | 0 | 0 |
| 31 Dec 16 | 0 | 0 | 0 | 0 |
| 31 Oct 16 | 0 | -1 | 1 | 0 |
| 31 Dec 15 | 0 | -1 | 1 | 0 |
Quality Earnings: WELL has a large one-off gain of CA$81.0M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: WELL became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: WELL has become profitable over the past 5 years, growing earnings by 60.5% per year.
Accelerating Growth: WELL has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: WELL has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (10.4%).
Return on Equity
High ROE: WELL's Return on Equity (10.3%) is considered low.